Journal of Clinical Oncology, Vol 17, Issue 3
(March), 1999: 813
© 1999 American Society for Clinical Oncology
Age, Sex, and Smoking Are Predictors of Circulating Insulin-Like Growth Factor 1 and Insulin-Like Growth FactorBinding Protein 3
Virginia G. Kaklamani,
Athena Linos,
Evangelia Kaklamani,
Ioanna Markaki,
Christos Mantzoros
From the Division of Endocrinology, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, MA; Department of Internal Medicine, Newton Wellesley Hospital, Newton, MA; and Department of Epidemiology, Athens University Medical School, Athens, Greece.
Address reprint requests to Christos Mantzoros, MD, DSc, Endocrinology, RN 325, Beth Israel Deaconess Medical Center, 99 Brookline Ave, Boston, MA 02215; email cmantzor{at}bidmc.harvard.edu
PURPOSE: Insulin-like growth factor (IGF-1) and its major binding protein (IGF-BP3) have recently been implicated in the pathogenesis of several malignancies. However, anthropometric and lifestyle predictors of these hormones have not been elucidated. Here we report the results of a cross-sectional study.
SUBJECTS AND METHODS: This cross-sectional study examines the relationship of a series of epidemiologic parameters (age, sex, height, body mass index, smoking, alcohol consumption, and coffee drinking) with IGF-1 and IGF-BP3 in a sample of 130 healthy adults.
RESULTS: We observed that serum levels of IGF-1 are higher, whereas levels of IGF-BP3 are lower, in men than in women. In addition, serum levels of IGF-1 are independently and negatively associated with age and positively associated with pack-year history of smoking. Finally, serum levels of IGF-BP3 are independently and negatively associated with the number of cigarettes smoked per day or pack-year history of smoking.
CONCLUSION: Age, sex, and smoking are independent predictors of IGF-1 and/or IGF-BP3. The influence of these epidemiologic variables on the pathogenesis of disease states associated with IGF-1 and IGF-BP3 warrants further exploration.

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. A. D'Aloisio, J. C. Schroeder, K. E. North, C. Poole, S. L. West, G. S. Travlos, and D. D. Baird
IGF-I and IGFBP-3 Polymorphisms in Relation to Circulating Levels among African American and Caucasian Women
Cancer Epidemiol. Biomarkers Prev.,
March 1, 2009;
18(3):
954 - 966.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-Y. Lee, Y. S. Chang, J.-Y. Han, D. D. Liu, J. J. Lee, R. Lotan, M. R. Spitz, and W. K. Hong
Effects of 9-cis-Retinoic Acid on the Insulin-Like Growth Factor Axis in Former Smokers
J. Clin. Oncol.,
July 1, 2005;
23(19):
4439 - 4449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A Lavigne, D. J Baer, H. H Wimbrow, P. S Albert, E. D Brown, J. T Judd, W. S Campbell, C. A Giffen, J. F Dorgan, T. J Hartman, et al.
Effects of alcohol on insulin-like growth factor I and insulin-like growth factor binding protein 3 in postmenopausal women
Am. J. Clinical Nutrition,
February 1, 2005;
81(2):
503 - 507.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Lavigne, H. H. Wimbrow, B. A. Clevidence, P. S. Albert, M. E. Reichman, W. S. Campbell, J. C. Barrett, S. D. Hursting, J. T. Judd, and P. R. Taylor
Effects of Alcohol and Menstrual Cycle on Insulin-like Growth Factor-I and Insulin-like Growth Factor Binding Protein-3
Cancer Epidemiol. Biomarkers Prev.,
December 1, 2004;
13(12):
2264 - 2267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Oh, W. Wu, G. Tortolero-Luna, R. Broaddus, D. M. Gershenson, T. W. Burke, R. Schmandt, and K. H. Lu
Increased Plasma Levels of Insulin-Like Growth Factor 2 and Insulin-Like Growth Factor Binding Protein 3 Are Associated with Endometrial Cancer Risk
Cancer Epidemiol. Biomarkers Prev.,
May 1, 2004;
13(5):
748 - 752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Lai, D. Vesprini, W. Zhang, M. J. Yaffe, M. Pollak, and S. A. Narod
A Polymorphic Locus in the Promoter Region of the IGFBP3 Gene Is Related to Mammographic Breast Density
Cancer Epidemiol. Biomarkers Prev.,
April 1, 2004;
13(4):
573 - 582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Z. Stolzenberg-Solomon, P. Limburg, M. Pollak, P. R. Taylor, J. Virtamo, and D. Albanes
Insulin-Like Growth Factor (IGF)-1, IGF-Binding Protein-3, and Pancreatic Cancer in Male Smokers
Cancer Epidemiol. Biomarkers Prev.,
March 1, 2004;
13(3):
438 - 444.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Decensi, U. Veronesi, R. Miceli, H. Johansson, L. Mariani, T. Camerini, M. G. Di Mauro, E. Cavadini, G. De Palo, A. Costa, et al.
Relationships between Plasma Insulin-like Growth Factor-I and Insulin-like Growth Factor Binding Protein-3 and Second Breast Cancer Risk in a Prevention Trial of Fenretinide
Clin. Cancer Res.,
October 15, 2003;
9(13):
4722 - 4729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. Probst-Hensch, H. Wang, V. H. H. Goh, A. Seow, H.-P. Lee, and M. C. Yu
Determinants of Circulating Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 Concentrations in a Cohort of Singapore Men and Women
Cancer Epidemiol. Biomarkers Prev.,
August 1, 2003;
12(8):
739 - 746.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Woodson, J. A. Tangrea, M. Pollak, T. D. Copeland, P. R. Taylor, J. Virtamo, and D. Albanes
Serum Insulin-like Growth Factor I: Tumor Marker or Etiologic Factor? A Prospective Study of Prostate Cancer among Finnish Men
Cancer Res.,
July 15, 2003;
63(14):
3991 - 3994.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Liu, F. Lian, D. E. Smith, R. M. Russell, and X.-D. Wang
Lycopene Supplementation Inhibits Lung Squamous Metaplasia and Induces Apoptosis via Up-Regulating Insulin-like Growth Factor-binding Protein 3 in Cigarette Smoke-exposed Ferrets
Cancer Res.,
June 15, 2003;
63(12):
3138 - 3144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Holmes, M. N. Pollak, and S. E. Hankinson
Lifestyle Correlates of Plasma Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 Concentrations
Cancer Epidemiol. Biomarkers Prev.,
September 1, 2002;
11(9):
862 - 867.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Teramukai, T. Rohan, H. Eguchi, T. Oda, K. Shinchi, and S. Kono
Anthropometric and Behavioral Correlates of Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 in Middle-aged Japanese Men
Am. J. Epidemiol.,
August 15, 2002;
156(4):
344 - 348.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kaaks, P. Toniolo, A. Akhmedkhanov, A. Lukanova, C. Biessy, H. Dechaud, S. Rinaldi, A. Zeleniuch-Jacquotte, R. E. Shore, and E. Riboli
Serum C-Peptide, Insulin-Like Growth Factor (IGF)-I, IGF-Binding Proteins, and Colorectal Cancer Risk in Women
J Natl Cancer Inst,
October 4, 2000;
92(19):
1592 - 1600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yu and T. Rohan
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
J Natl Cancer Inst,
September 20, 2000;
92(18):
1472 - 1489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. G. Kaklamani, A. Linos, E. Kaklamani, I. Markaki, Y. Koumantaki, and C. S. Mantzoros
Dietary Fat and Carbohydrates Are Independently Associated With Circulating Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor–Binding Protein 3 Concentrations in Healthy Adults
J. Clin. Oncol.,
October 1, 1999;
17(10):
3291 - 3298.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|